| Literature DB >> 35371378 |
Tufa Gemechu Weyessa1, Endeshaw Asaye Kindie2, Ermias Teklehaimanot Yefter2.
Abstract
Introduction: there is few data on epidemiology or clinico-pathology of primary bone tumours in Ethiopia. Bone tumors often have a similar presentation and clinical approach, but they present individual characteristics that are important for treatment and prognosis. This study aimed to provide a brief overview of histopathological pattern of primary bone tumours and the distribution of specific diagnosis by age, sex and anatomic locations.Entities:
Keywords: Histopathological pattern; age; bone tumors; location; sex
Mesh:
Year: 2022 PMID: 35371378 PMCID: PMC8933449 DOI: 10.11604/pamj.2022.41.62.27905
Source DB: PubMed Journal: Pan Afr Med J
distribution of benign tumours of bone by histologic type and age of patient as seen in the Department of Pathology, Faculty of Medicine, Addis Ababa University, 2015-2019
| Histologic type | Age group in yrs | Total no. of cases | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 0-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60-69 | 70-79 | ||
| Osteochondroma | 3 | 35 | 9 | 1 | 2 | 1 | 0 | 0 | 51 |
| Chondroma | 1 | 10 | 2 | 4 | 1 | 0 | 0 | 0 | 18 |
| Chondromyxoid fibroma | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| chondroblastoma | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| BPOP | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 2 |
| Synovial chondromatosis | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 2 |
| Ossifying fibroma | 0 | 3 | 6 | 0 | 0 | 0 | 0 | 0 | 9 |
| Fibrous dysplasia | 3 | 2 | 8 | 1 | 2 | 0 | 0 | 0 | 16 |
| Osteofibrous dysplasia | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2 |
| Non-ossifying fibroma | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
| GCT | 1 | 4 | 10 | 2 | 1 | 1 | 0 | 0 | 19 |
| GCT with ABC | 0 | 3 | 3 | 0 | 1 | 0 | 0 | 0 | 7 |
| ABC | 1 | 5 | 0 | 1 | 1 | 0 | 0 | 0 | 8 |
| Osteoma | 0 | 2 | 4 | 4 | 3 | 1 | 0 | 0 | 14 |
| Osteoblastoma | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
| Hemangioma | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| Total | 14 | 68 | 42 | 17 | 12 | 4 | 0 | 1 | 158 |
BPOP: bizarre parosteal osteochondromatous proliferation; GCT: giant cell tumour; ABC: aneurysmal bone cyst
distribution of malignant tumours of bone by histologic type and age of patient as seen in the Department of Pathology, Faculty of Medicine, Addis Ababa University, 2015-2019
| Histologic type | Age group in years | Total no. of cases | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 0-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60-69 | 70-79 | ||
| Osteosarcoma | 4 | 58 | 34 | 7 | 4 | 1 | 1 | 0 | 109 |
| Chondrosarcoma | 0 | 0 | 3 | 3 | 2 | 6 | 4 | 2 | 20 |
| Multiple myeloma | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 4 |
| Plasmacytoma | 0 | 0 | 0 | 1 | 5 | 5 | 1 | 1 | 13 |
| Ewing sarcoma | 3 | 16 | 7 | 1 | 0 | 0 | 0 | 0 | 27 |
| Angiosarcoma | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 2 |
| Chordoma | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 2 |
| Total | 7 | 74 | 44 | 12 | 13 | 15 | 8 | 4 | 177 |
distribution of benign tumours of bone by histologic type and sex as seen in the Department of Pathology, Faculty of Medicine, Addis Ababa University, 2015-2019
| Benign bone tumors | No. of males | Percent (%) | No. of females | Percent (%) | Total no. of cases | Percent (%) |
|---|---|---|---|---|---|---|
| Osteochondroma | 27 | 53% | 24 | 47% | 51 | 32.3% |
| Chondroma | 6 | 33% | 12 | 67% | 18 | 11% |
| Chondromyxoid fibroma | 1 | 100% | 0 | 0% | 1 | 0.6% |
| Chondroblastoma | 1 | 100% | 0 | 0% | 1 | 0.6% |
| Synovial chondromatosis | 0 | 0% | 2 | 100% | 2 | 1.3% |
| BPOP | 2 | 100% | 0 | 0% | 2 | 1.3% |
| Osteoma | 5 | 36% | 9 | 64% | 14 | 9% |
| Osteoblastoma | 1 | 50% | 1 | 50% | 2 | 1.3% |
| Ossifying fibroma | 1 | 11% | 8 | 89% | 9 | 6% |
| Fibrous dysplasia | 6 | 37.5% | 10 | 62.5% | 16 | 10% |
| Osteofibrous dysplasia | 1 | 50% | 1 | 50% | 2 | 1.3% |
| Non-ossifying fibroma | 3 | 60% | 2 | 40% | 5 | 3.2% |
| Giant cell tumor | 12 | 63% | 7 | 37% | 19 | 12% |
| GCT with ABC | 2 | 29% | 5 | 71% | 7 | 4.5% |
| ABC | 4 | 50% | 4 | 50% | 8 | 5% |
| Hemangioma | 0 | 0% | 1 | 100% | 1 | 0.6% |
| Total | 72 | 46% | 86 | 54% | 158 | 100% |
BPOP: bizarre parosteal osteochondromatous proliferation; GCT: giant cell tumour; ABC: aneurysmal bone cyst
distribution of primary malignant tumours of bone by histologic type and sex as seen in the Department of Pathology, Faculty of Medicine, Addis Ababa University, 2015-2019
| Malignant bone tumors | Number of males | Percent (%) | Number of females | Percent (%) | Total number of cases | Percent (%) |
|---|---|---|---|---|---|---|
| Osteosarcoma | 65 | 60% | 44 | 40% | 109 | 62% |
| Chondrosarcoma | 11 | 55% | 9 | 45% | 20 | 11.3% |
| Plasmacytoma | 8 | 62% | 5 | 38% | 13 | 7.3% |
| Plasma cell myeloma | 4 | 100% | 0 | 0% | 4 | 2.2% |
| Ewing sarcoma | 19 | 70% | 8 | 30% | 27 | 15.2% |
| Angiosarcoma | 1 | 50% | 1 | 50% | 2 | 1% |
| Chordoma | 2 | 100% | 0 | 0% | 2 | 1% |
| Total | 110 | 62% | 67 | 38% | 177 | 100% |
skeletal distribution of benign and malignant tumours of bone as seen in the Department of Pathology, Faculty of Medicine, Addis Ababa University, 2015-2019
| Skeletal location in percentage (%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Benign bone tumors | Knee* | Pelvis# | Shoulder girdle | Lower leg | Upper limb | Trunk | Face and skull bone | Jaw bone | Others |
| Osteochondroma | 60% | 8% | 10% | 2% | 6% | 4% | 0% | 0% | 10% |
| Chondroma | 11% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 89% |
| Chondromyxoid fibroma | 100% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Chondroblastoma | 0% | 0% | 100% | 0% | 0% | 0% | 0% | 0% | 0% |
| Synovial chondromatosis | 100% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| BPOP | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 100% |
| Ossifying fibroma | 0% | 0% | 0% | 0% | 0% | 0% | 44% | 56% | 0% |
| Fibrous dysplasia | 13% | 0% | 6% | 0% | 0% | 6% | 19% | 56% | 0% |
| Osteofibrous dysplasia | 0% | 0% | 0% | 100% | 0% | 0% | 0% | 0% | 0% |
| Non-ossifying fibroma | 100% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Giant cell tumor | 37% | 5% | 0% | 11% | 5% | 0% | 0% | 5% | 37% |
| GCT with ABC | 86% | 14% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Aneurysmal bone cyst | 12.5% | 25% | 25% | 0% | 0% | 25% | 0% | 0% | 12.5% |
| Osteoma | 0% | 0% | 0% | 0% | 0% | 0% | 100% | 0% | 0% |
| Osteoblastoma | 100% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Hemangioma | 0% | 0% | 0% | 0% | 0% | 0% | 100% | 0% | 0% |
| All diagnoses | 37% | 5% | 6% | 3% | 3% | 3% | 14% | 9% | 20% |
|
| |||||||||
| Osteosarcoma | 72% | 9% | 8% | 0% | 4% | 2% | 0% | 5% | 0% |
| Chondrosarcoma | 20% | 30% | 25% | 5% | 5% | 15% | 0% | 0% | 0% |
| Multiple myeloma | 0% | 25% | 0% | 0% | 0% | 25% | 25% | 25% | 0% |
| Plasmacytoma | 23% | 0% | 8% | 8% | 0% | 53% | 0% | 8% | 0% |
| Ewing sarcoma | 22% | 33% | 15% | 7% | 4% | 19% | 0% | 0% | 0% |
| Angiosarcoma | 0% | 50% | 0% | 0% | 50% | 0% | 0% | 0% | 0% |
| Chordoma | 0% | 100% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| All diagnoses | 52% | 16% | 11% | 2% | 4% | 10% | 1% | 4% | 0% |
Data from 335 primary bone tumours seen at Black Lion Specialized and Teaching Hospital, Ethiopia; *knee tumors include distal femur, proximal tibia and proximal fibula; #pelvis tumors include pelvis and proximal femur locations; shoulder girdle tumors include proximal humerus, clavicle and scapula; trunk includes vertebrae, ribs, sternum etc.; others include ankle joint, short tubular bones of the hands and feet